72 related articles for article (PubMed ID: 11038750)
21. The interaction of antigenic peptides with the H-2Kd MHC class I molecule.
Maryanski JL; Lüthy R; Romero P; Healy F; Drouet C; Casanova JL; Jaulin C; Kourilsky P; Corradin G
Semin Immunol; 1993 Apr; 5(2):95-104. PubMed ID: 8504219
[TBL] [Abstract][Full Text] [Related]
22. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
Schiewe AJ; Haworth IS
J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
[TBL] [Abstract][Full Text] [Related]
23. PREDNOD, a prediction server for peptide binding to the H-2g7 haplotype of the non-obese diabetic mouse.
Rajapakse M; Zhang GL; Srinivasan KN; Schmidt B; Petrovsky N; Brusic V
Autoimmunity; 2006 Dec; 39(8):645-50. PubMed ID: 17178561
[TBL] [Abstract][Full Text] [Related]
24. H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo.
Tang XD; Wan Y; Chen L; Chen T; Yu ST; Xiong Z; Fang DC; Liang GP; Yang SM
Cancer Res; 2008 Mar; 68(5):1529-37. PubMed ID: 18316618
[TBL] [Abstract][Full Text] [Related]
25. Circular dichroism determination of class I MHC-peptide equilibrium dissociation constants.
Morgan CS; Holton JM; Olafson BD; Bjorkman PJ; Mayo SL
Protein Sci; 1997 Aug; 6(8):1771-3. PubMed ID: 9260291
[TBL] [Abstract][Full Text] [Related]
26. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
[TBL] [Abstract][Full Text] [Related]
27. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
28. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
[TBL] [Abstract][Full Text] [Related]
29. Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules.
Gomez-Nunez M; Pinilla-Ibarz J; Dao T; May RJ; Pao M; Jaggi JS; Scheinberg DA
Leuk Res; 2006 Oct; 30(10):1293-8. PubMed ID: 16533527
[TBL] [Abstract][Full Text] [Related]
30. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H
Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253
[TBL] [Abstract][Full Text] [Related]
31. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
32. Enhancing cytotoxic T cell responses with altered-peptide ligands.
Zhao R; Collins EJ
Arch Immunol Ther Exp (Warsz); 2001; 49(4):271-7. PubMed ID: 11726029
[TBL] [Abstract][Full Text] [Related]
33. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y
J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794
[TBL] [Abstract][Full Text] [Related]
34. Peptide binding to MHC class I is determined by individual pockets in the binding groove.
Johansen TE; McCullough K; Catipovic B; Su XM; Amzel M; Schneck JP
Scand J Immunol; 1997 Aug; 46(2):137-46. PubMed ID: 9583994
[TBL] [Abstract][Full Text] [Related]
35. Role for MHC class I molecules in selecting and protecting high affinity peptides in the presence of proteases.
Ojcius DM; Langlade-Demoyen P; Gachelin G; Kourilsky P
J Immunol; 1994 Mar; 152(6):2798-810. PubMed ID: 8144883
[TBL] [Abstract][Full Text] [Related]
36. Positive selection of the T-cell repertoire is affected by mutations in the peptide-binding site of MHC class I molecules.
Nikolić-Zugić J; Dyall R
Ann N Y Acad Sci; 1993 Jun; 681():16-24. PubMed ID: 8395147
[TBL] [Abstract][Full Text] [Related]
37. A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets.
Altuvia Y; Sette A; Sidney J; Southwood S; Margalit H
Hum Immunol; 1997 Nov; 58(1):1-11. PubMed ID: 9438204
[TBL] [Abstract][Full Text] [Related]
38. Identification of H-2Kb-, Db- and Dd-binding peptides derived from amino acid sequences of polyoma virus T antigens.
Reinholdsson-Ljunggren G; Franksson L; Dalianis T; Ljunggren HG
Int J Cancer; 1993 Jul; 54(6):992-5. PubMed ID: 8335406
[TBL] [Abstract][Full Text] [Related]
39. Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides.
Hudrisier D; Mazarguil H; Oldstone MB; Gairin JE
Mol Immunol; 1995 Aug; 32(12):895-907. PubMed ID: 7565816
[TBL] [Abstract][Full Text] [Related]
40. Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design.
Apostolopoulos V; McKenzie IF; Wilson IA
Front Biosci; 2001 Oct; 6():D1311-20. PubMed ID: 11578952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
